ALERT: This system is being upgraded on Tuesday December 12. It will not be available
for use for several hours that day while the upgrade is in progress. Deposits to DukeSpace
will be disabled on Monday December 11, so no new items are to be added to the repository
while the upgrade is in progress. Everything should be back to normal by the end of
day, December 12.
Evaluating the number of stages in development of squamous cell and adenocarcinomas across cancer sites using human population-based cancer modeling.
dc.contributor.author | Kravchenko, Julia | |
dc.contributor.author | Akushevich, Igor | |
dc.contributor.author | Abernethy, Amy P | |
dc.contributor.author | Lyerly, H Kim | |
dc.coverage.spatial | United States | |
dc.date.accessioned | 2017-06-06T15:54:49Z | |
dc.date.available | 2017-06-06T15:54:49Z | |
dc.date.issued | 2012 | |
dc.identifier | https://www.ncbi.nlm.nih.gov/pubmed/22629394 | |
dc.identifier | PONE-D-12-02029 | |
dc.identifier.uri | https://hdl.handle.net/10161/14850 | |
dc.description.abstract | BACKGROUND: Adenocarcinomas (ACs) and squamous cell carcinomas (SCCs) differ by clinical and molecular characteristics. We evaluated the characteristics of carcinogenesis by modeling the age patterns of incidence rates of ACs and SCCs of various organs to test whether these characteristics differed between cancer subtypes. METHODOLOGY/PRINCIPAL FINDINGS: Histotype-specific incidence rates of 14 ACs and 12 SCCs from the SEER Registry (1973-2003) were analyzed by fitting several biologically motivated models to observed age patterns. A frailty model with the Weibull baseline was applied to each age pattern to provide the best fit for the majority of cancers. For each cancer, model parameters describing the underlying mechanisms of carcinogenesis including the number of stages occurring during an individual's life and leading to cancer (m-stages) were estimated. For sensitivity analysis, the age-period-cohort model was incorporated into the carcinogenesis model to test the stability of the estimates. For the majority of studied cancers, the numbers of m-stages were similar within each group (i.e., AC and SCC). When cancers of the same organs were compared (i.e., lung, esophagus, and cervix uteri), the number of m-stages were more strongly associated with the AC/SCC subtype than with the organ: 9.79±0.09, 9.93±0.19 and 8.80±0.10 for lung, esophagus, and cervical ACs, compared to 11.41±0.10, 12.86±0.34 and 12.01±0.51 for SCCs of the respective organs (p<0.05 between subtypes). Most SCCs had more than ten m-stages while ACs had fewer than ten m-stages. The sensitivity analyses of the model parameters demonstrated the stability of the obtained estimates. CONCLUSIONS/SIGNIFICANCE: A model containing parameters capable of representing the number of stages of cancer development occurring during individual's life was applied to the large population data on incidence of ACs and SCCs. The model revealed that the number of m-stages differed by cancer subtype being more strongly associated with ACs/SCCs histotype than with organ/site. | |
dc.language | eng | |
dc.publisher | Public Library of Science (PLoS) | |
dc.relation.ispartof | PLoS One | |
dc.relation.isversionof | 10.1371/journal.pone.0037430 | |
dc.subject | Adenocarcinoma | |
dc.subject | Adult | |
dc.subject | Age Distribution | |
dc.subject | Aged | |
dc.subject | Aged, 80 and over | |
dc.subject | Carcinoma, Squamous Cell | |
dc.subject | Cohort Studies | |
dc.subject | Esophageal Neoplasms | |
dc.subject | Female | |
dc.subject | Humans | |
dc.subject | Incidence | |
dc.subject | Lung Neoplasms | |
dc.subject | Middle Aged | |
dc.subject | Models, Statistical | |
dc.subject | SEER Program | |
dc.subject | Sensitivity and Specificity | |
dc.subject | United States | |
dc.subject | Uterine Cervical Neoplasms | |
dc.title | Evaluating the number of stages in development of squamous cell and adenocarcinomas across cancer sites using human population-based cancer modeling. | |
dc.type | Journal article | |
duke.contributor.id | Akushevich, Igor|0285458 | |
duke.contributor.id | Abernethy, Amy P|0050834 | |
duke.contributor.id | Lyerly, H Kim|0117267 | |
pubs.author-url | https://www.ncbi.nlm.nih.gov/pubmed/22629394 | |
pubs.begin-page | e37430 | |
pubs.issue | 5 | |
pubs.organisational-group | Basic Science Departments | |
pubs.organisational-group | Clinical Science Departments | |
pubs.organisational-group | Duke | |
pubs.organisational-group | Duke Cancer Institute | |
pubs.organisational-group | Duke Clinical Research Institute | |
pubs.organisational-group | Duke Population Research Institute | |
pubs.organisational-group | Immunology | |
pubs.organisational-group | Institutes and Centers | |
pubs.organisational-group | Institutes and Provost's Academic Units | |
pubs.organisational-group | Medicine | |
pubs.organisational-group | Medicine, Medical Oncology | |
pubs.organisational-group | Nursing | |
pubs.organisational-group | Pathology | |
pubs.organisational-group | Physics | |
pubs.organisational-group | Sanford School of Public Policy | |
pubs.organisational-group | School of Medicine | |
pubs.organisational-group | School of Nursing | |
pubs.organisational-group | Social Science Research Institute | |
pubs.organisational-group | Surgery | |
pubs.organisational-group | Surgery, Surgical Sciences | |
pubs.organisational-group | Trinity College of Arts & Sciences | |
pubs.organisational-group | University Institutes and Centers | |
pubs.publication-status | Published | |
pubs.volume | 7 | |
dc.identifier.eissn | 1932-6203 | |
duke.contributor.orcid | Lyerly, H Kim|0000-0002-0063-4770 |
Files in this item
This item appears in the following Collection(s)
- Scholarly Articles
Articles